KATHERINE DORMAN: Open Payments
NPI 1336601210 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 35 payments from 16 companies in 2025. Trend: 2023 $439 · 2024 $455 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Corcept Therapeutics | 3 | $76 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| PFIZER INC. | 3 | $42 |
| Lilly USA, LLC | 2 | $35 |
| Radius Health, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Smith+Nephew, Inc. | 1 | $24 |
Products named: FREESTYLE LIBRE 3, CAPLYTA, Korlym, ZENPEP, FARXIGA, AIRSUPRA, Tymlos, ENTRESTO.
Industry payments across AZ — which companies pay providers there.
